Key Takeaways: Verigraft AB bridges the gap in regenerative medicine by creating personalized tissue-engineered transplants. The company’s unique technology platform transforms donated tissue into autologous-like tissue, avoiding transplant rejection and eliminating the need for life-long immunosuppression. Verigraft’s approach profoundly impacts patients’ lives and provides
Read More